Cargando…
MLH1 Promoter Methylation Could Be the Second Hit in Lynch Syndrome Carcinogenesis
(1) Background: MLH1 hypermethylation is an epigenetic alteration in the tumorigenesis of colorectal cancer (CRC) and endometrial cancer (EC), causing gene silencing, and, as a consequence, microsatellite instability. Commonly, MLH1 hypermethylation is considered a somatic and sporadic event in canc...
Autores principales: | Carnevali, Ileana Wanda, Cini, Giulia, Libera, Laura, Sahnane, Nora, Facchi, Sofia, Viel, Alessandra, Sessa, Fausto, Tibiletti, Maria Grazia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670941/ https://www.ncbi.nlm.nih.gov/pubmed/38003003 http://dx.doi.org/10.3390/genes14112060 |
Ejemplares similares
-
Similarities and differences in gene expression profiles of BRCA1 methylated and mutated epithelial ovarian cancers
por: Sahnane, Nora, et al.
Publicado: (2023) -
BRCA Methylation Testing Identifies a Subset of Ovarian Carcinomas without Germline Variants That Can Benefit from PARP Inhibitor
por: Sahnane, Nora, et al.
Publicado: (2020) -
Case Report: Male Lobular Breast Cancer in Hereditary Cancer Syndromes
por: Carnevali, Ileana, et al.
Publicado: (2022) -
OncoPan(®): An NGS-Based Screening Methodology to Identify Molecular Markers for Therapy and Risk Assessment in Pancreatic Ductal Adenocarcinoma
por: Tibiletti, Maria Grazia, et al.
Publicado: (2022) -
Gut Microbiota Analysis in Postoperative Lynch Syndrome Patients
por: Mori, Giorgia, et al.
Publicado: (2019)